The topography of cell loss from locus caeruleus in Alzheimer's disease.
about
Alzheimer's therapeutics: translation of preclinical science to clinical drug developmentThe preclinical phase of the pathological process underlying sporadic Alzheimer's diseaseNeuropharmacology and receptor studies in the elderly.Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer's disease.Neurotransmitter replacement therapy in Alzheimer's disease.Distinct glutaminyl cyclase expression in Edinger-Westphal nucleus, locus coeruleus and nucleus basalis Meynert contributes to pGlu-Abeta pathology in Alzheimer's disease.Targeting axonal protein synthesis in neuroregeneration and degeneration.Early neurone loss in Alzheimer's disease: cortical or subcortical?Reduced tissue levels of noradrenaline are associated with behavioral phenotypes of the TgCRND8 mouse model of Alzheimer's disease.The locus coeruleus-norepinephrine network optimizes coupling of cerebral blood volume with oxygen demandOrexin-A is Associated with Increases in Cerebrospinal Fluid Phosphorylated-Tau in Cognitively Normal Elderly Subjects.Epigenetic dysregulation of brainstem nuclei in the pathogenesis of Alzheimer's disease: looking in the correct place at the right time?Activation of the metabotropic glutamate receptor attenuates N-methyl-D-aspartate neurotoxicity in cortical cultures.Exercise-induced noradrenergic activation enhances memory consolidation in both normal aging and patients with amnestic mild cognitive impairment.The pathogenesis and progression of the pathological changes of Alzheimer's disease.Dysfunctional Sensory Modalities, Locus Coeruleus, and Basal Forebrain: Early Determinants that Promote Neuropathogenesis of Cognitive and Memory Decline and Alzheimer's Disease.Conditional Depletion of Hippocampal Brain-Derived Neurotrophic Factor Exacerbates Neuropathology in a Mouse Model of Alzheimer's Disease.The basis for behavioural disturbances in dementia.Axonally synthesized ATF4 transmits a neurodegenerative signal across brain regions.Decreased density of presynaptic alpha 2-adrenoceptors in postmortem brains of patients with Alzheimer's disease.Alzheimer disease neuropathology: understanding autonomic dysfunction.The cerebellum in Alzheimer's disease: evaluating its role in cognitive decline.Reply: the early pathological process in sporadic Alzheimer's disease.Amyloid or tau: the chicken or the egg?Locus ceruleus degeneration is ubiquitous in Alzheimer's disease: possible implications for diagnosis and treatment.Differential age-related loss of pigmented locus coeruleus neurons in suicides, alcoholics, and alcoholic suicides.Immunohistochemical evidence of neuroprotection by R(-)-deprenyl and N-(2-hexyl)-N-methylpropargylamine on DSP-4-induced degeneration of rat brain noradrenergic axons and terminals.The selective vulnerability of brainstem nuclei to Alzheimer's disease.Kinetics of serotonin oxidation by heme-Aβ relevant to Alzheimer's disease.The age of onset and evolution of Braak tangle stage and Thal amyloid pathology of Alzheimer's disease in individuals with Down syndrome.
P2860
Q26829267-B1E91D6A-12E7-45E8-81F1-686A897BA762Q28083428-C47494DE-146F-4B3D-B4AE-ADAD9AD31956Q30585270-7C34D26E-BB18-4756-946D-F8EEAF7B001EQ30844298-EA517A9B-CB7F-4EDA-B680-114A5C134258Q33921314-611C6A13-686F-4CF0-8902-C9158D7483CBQ33942884-637E19C9-9163-45D5-98BD-55581F170B3EQ35064944-2F0D278F-708A-4DE8-AFA4-6BA6F7FDF592Q35176873-FF1D6980-CF86-4196-8200-B114579D6C33Q36035950-94A7BB75-965C-497B-ABA8-386FD0B10AF1Q36459060-C9767BD8-DD3C-4824-85EB-BDD40A9084D3Q36890131-418F2B68-3ABA-4FEF-973C-061123B3BF25Q37590630-AF9BDD39-5799-4FC1-89EC-D16D22370604Q37610923-EABCD67C-6968-4AC6-BF0F-D4DF90EF4AE0Q37634197-C1C5228F-C429-455D-B4F8-F3A821BB935FQ38677444-AAF66980-B299-415D-BD5F-09B7B8ECA7FAQ38875190-CF91A5FA-ABF8-4D0A-B4BD-2C63B5BCBC59Q38925596-5C23322C-CF49-4FED-800E-FBC8410D299FQ41033994-F36DEDE0-F753-4BB4-AEC9-24681E95A6D2Q42852011-F989781A-8321-480D-93C4-F66881315F5BQ43718496-2B62D46A-E553-4A8C-9573-942CC4EFEF5AQ47094454-49A1C26C-C820-4672-9331-3152549AE339Q47592930-97385D46-6A05-4371-BFE9-0FB5B793575CQ47685999-D7C94D73-7C08-4C5C-9C90-F3E7B0F43283Q47832745-CFA65A2C-2E99-4E19-A887-E196AFBFF18BQ48319151-91B0AB76-A138-484A-94C3-844A4799BE44Q48903836-9C44CE93-6AFA-4606-84FD-EC15F77C2603Q49116462-1FA9655D-2112-4FE3-815A-EF64D7F1FBBEQ53240462-CF4D931F-95C9-4FA4-9672-137C25EE4F4FQ53469156-628D0A0F-89C3-4F26-B418-C00ACD53335DQ55455361-8E96A5A0-0590-40D2-86B3-A5DA88BBF061
P2860
The topography of cell loss from locus caeruleus in Alzheimer's disease.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
The topography of cell loss from locus caeruleus in Alzheimer's disease.
@en
The topography of cell loss from locus caeruleus in Alzheimer's disease.
@nl
type
label
The topography of cell loss from locus caeruleus in Alzheimer's disease.
@en
The topography of cell loss from locus caeruleus in Alzheimer's disease.
@nl
prefLabel
The topography of cell loss from locus caeruleus in Alzheimer's disease.
@en
The topography of cell loss from locus caeruleus in Alzheimer's disease.
@nl
P2093
P1476
The topography of cell loss from locus caeruleus in Alzheimer's disease.
@en
P2093
P304
P356
10.1016/0022-510X(86)90179-6
P577
1986-12-01T00:00:00Z